Biocon Limited has informed the Exchange regarding a press release dated May 24, 2024, titled "Biocon Limited signs exclusive licensing and supply deal for the commercialization of Liraglutide in South Korea with Handok Inc.".
Biocon Limited has informed the Exchange regarding a press release dated May 24, 2024, titled "Biocon Limited signs exclusive licensing and supply deal for the commercialization of Liraglutide in South Korea with Handok Inc.".